article thumbnail

The Cardiometabolic Event of the Year: What to Expect at the 19th Annual Cardiometabolic Health Congress (CMHC) 

Cardiometabolic Health Congress

A jam-packed, expertly curated agenda will highlight the latest and most impactful advancements in cardiorenal metabolic medicine and protocols for future-focused, whole-patient care. The robust conference agenda begins with FDA updates and advancements in cardiorenal metabolic care.

article thumbnail

Endotronix Receives FDA Premarket Approval of the Cordella PA Sensor System for the Treatment of Heart Failure

DAIC

Cordella is a proactive HF management platform that delivers daily PA pressure and other vital data via an implantable sensor and user-friendly, non-invasive health tools, respectively, to a managing HF clinician for remote patient care. Reimbursement for implantation and ongoing management through existing reimbursement pathways. "At

article thumbnail

K Health to Collaborate with Mayo Clinic on Cardiac Clinical Artificial Intelligence (AI) Solution

DAIC

The goal of the cardiac program is to use proprietary algorithms built by K Health to power advanced AI-ECG (AI-enhanced electrocardiography) technology, risk assessments, and remote patient monitoring, according to the statement. The project is slated to begin in early 2024, reported the Jan.

article thumbnail

What’s wrong with the NHS? – Part 4

Dr. Malcolm Kendrick

Here, for example, plucked at random, is a reference to the latest NICE guidelines on the management of hypertension (high blood pressure) in adults. But this, the primary guideline on hypertension for adults, is but one of many. There are associated guidelines on hypertension in pregnancy. Primary care, secondary care.

article thumbnail

2024’s Mid-Year Review: FDA-Approved Cardiorenal Metabolic Drugs and Devices 

Cardiometabolic Health Congress

Staying informed about these cutting-edge developments is critical for providing exceptional patient care. Join us as we examine the landmark approvals that are revolutionizing patient outcomes. The first half of 2024 has ushered in a wave of transformative FDA approvals in cardiorenal metabolic health.

article thumbnail

Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 1) 

Cardiometabolic Health Congress

One promising strategy is the formation of creative partnerships between patients and their healthcare teams. We can revolutionize patient care and significantly reduce cardiometabolic risk by fostering collaborative relationships and leveraging diverse expertise and experiences.

article thumbnail

History & Future of Cardiac Remote Patient Monitoring

Vector Remote

Available as software with service or a software-only solution, clinics and their patients are invited to try The Vector Patient Care Platform™. Let’s discuss how the future of cardiac remote patient monitoring can help improve your clinic.